Record overview
Status and phase
Status: NOT_YET_RECRUITING
Phase: PHASE1, PHASE2
Sponsor: Centre Hospitalier Universitaire de Saint Etienne
Condition: Myeloma Multiple
NCT07612787
A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed Multiple Myeloma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.